Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03798093
Other study ID # MINVI Echo Study
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 7, 2019
Est. completion date November 4, 2022

Study information

Verified date January 2024
Source Sharp HealthCare
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Non-vigorous infants enrolled in the MINVI trial will be approached for consent for ongoing data collection. As part of the data collection, an optional echocardiogram will be performed if the parent consents.


Description:

Non-vigorous infants enrolled in the MINVI trial will be approached for consent for ongoing data collection. As part of the data collection, an optional echocardiogram will be performed if the parent consents. The consent will have a check box to indicate if they consent to the additional test. Echocardiographic measurements will be performed on all infants at 12 hours +/-3 hours of age by our research sonographers who are blinded to infant randomization. Measurements will be taken according to a standard operating procedure to assess systemic blood flow, by superior vena cava (SVC) flow (ml/kg/min), right ventricular output (ml/kg/min), left ventricular output (LVO) (ml/kg/min), measures of left and right venitricular tissue Doppler and strain imaging. These measurements will be performed off line at a later time. Data will be entered into REDCap. If any structural abnormalities are found, the attending pediatrician will be notified of the abnormal echocardiogram. The consent will clearly state that this echo is not for diagnostic purposes. Any additional studies including an official complete echocardiogram and or cardiology consultation will be left to the discretion of the attending pediatrician, as he/she deems necessary


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date November 4, 2022
Est. primary completion date June 1, 2021
Accepts healthy volunteers No
Gender All
Age group 35 Weeks to 42 Weeks
Eligibility Inclusion Criteria: Non-vigorous newborns born between 35-42 weeks gestation Exclusion Criteria: Known major congenital or chromosomal anomalies of newborn Known cardiac defects other than small ASD, VSD and PDA Complete placental abruption/cutting through the placenta at time of delivery Monochorionic multiples Cord Avulsion Presence of non-reducible nuchal cord Perinatal providers unaware of the protocol

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Umbilical Cord Milking
At delivery, the umbilical cord is grasped, and blood is pushed toward the infant 4 times before the cord is clamped. This procedure infuses a placental transfusion of blood into the infant and can be done in 15-20 seconds.
Early Cord Clamping
The umbilical cord is clamped within 30 seconds of delivery.

Locations

Country Name City State
United States Sharp Mary Birch Hospital for Women and Newborns San Diego California

Sponsors (2)

Lead Sponsor Collaborator
Sharp HealthCare Sharp Mary Birch Hospital for Women & Newborns

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiac Output Cardiac Output measured by Left Ventricular Output 12 +/- 6 hours of life
Secondary Right Ventricular Output Obtained from the modified short axis view of Cardiac Ultrasound 12 +/- 6 hours of life
Secondary SVC Flow SVC flow (Diameter obtained from the infaclavicular view (hybrid view), Doppler from the subcostal view) 12 +/- 6 hours of life
Secondary Peak Systolic Strain and Strain rate Measures of Left and Right Ventricular Strain and Strain rate 12 +/- 6 hours of life
Secondary Peak Systolic Tissue Doppler Measure of left and right ventricular peak systolic Tissue Doppler velocity 12 +/- 6 hours of life
See also
  Status Clinical Trial Phase
Completed NCT01913340 - Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO) Phase 1/Phase 2
Active, not recruiting NCT04169191 - Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia Phase 1
Completed NCT02858583 - SI + CC Versus 3:1 C:V Ratio During Neonatal CPR N/A
Recruiting NCT03682042 - Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries Developmental Follow Up N/A
Recruiting NCT03657394 - Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries N/A
Withdrawn NCT03681314 - Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU) N/A
Completed NCT02862925 - Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings. N/A
Completed NCT01751945 - Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project N/A
Terminated NCT03885492 - The Baby-Saver Kit: Clinical Testing of a Device for Neonatal Resuscitation With Intact Cord in Uganda
Completed NCT01743742 - First-day High Dose Vitamin C, E in Severe Birth Asphyxia Phase 4
Completed NCT05946681 - Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
Recruiting NCT03577054 - Development of a Mobile Application for HBB Prompt Study N/A
Active, not recruiting NCT05854745 - Comparison of Virtual Training to In-Person Training of Helping Babies Breathe in Ethiopia N/A
Not yet recruiting NCT05707962 - Neuroprotective Efficacy of Postnatal Magnesium Sulphate in Term Infants With Birth Asphyxia N/A
Completed NCT01869582 - Safer Births - Reducing Perinatal Mortality N/A
Completed NCT01350765 - Naushero Feroze Neonatal Survival Project N/A
Recruiting NCT04043299 - Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes Phase 3
Completed NCT01865656 - A Skills and Drills Intervention for Emergency Obstetrics and Neonatal Care at First Referral Units of North Karnataka N/A
Active, not recruiting NCT04714502 - Asphyxia Associated Metabolite Biomarker Investigation 2
Recruiting NCT05275725 - Finding Solutions to Thrive After Birth Asphyxia in Africa Phase 1